CoChat
Sign Up
Cited by 246Memory and Neural MechanismsNeuroscience and Neuropharmacology ResearchPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory Formation

Open access
Slipczuk, Leandro, Bekinschtein, Pedro, Katche, Cynthia, Cammarota, Martín, Izquierdo, Iván, Medina, Jorge H.·2009·PLoS ONE
DOI 10.1371/journal.pone.0006007PMC PMC2695538
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: The mammalian target of Rapamycin (mTOR) kinase plays a key role in translational control of a subset of mRNAs through regulation of its initiation step. In neurons, mTOR is present at the synaptic region, where it modulates the activity-dependent expression of locally-translated proteins independently of mRNA synthesis. Indeed, mTOR is necessary for different forms of synaptic plasticity and long-term memory (LTM) formation. However, little is known about the time course of mTOR activation and the extracellular signals governing this process or the identity of the proteins whose translation is regulated by this kinase, during mnemonic processing. METHODOLOGY/PRINCIPAL FINDINGS: Here we show that consolidation of inhibitory avoidance (IA) LTM entails mTOR activation in the dorsal hippocampus at the moment of and 3 h after training and is associated with a rapid and rapamycin-sensitive increase in AMPA receptor GluR1 subunit expression, which was also blocked by intra-hippocampal delivery of GluR1 antisense oligonucleotides (ASO). In addition, we found that pre- or post-training administration of function-blocking anti-BDNF antibodies into dorsal CA1 hampered IA LTM retention, abolished the learning-induced biphasic activation of mTOR and its readout, p70S6K and blocked GluR1 expression, indicating that BDNF is an upstream factor controlling mTOR signaling during fear-memory consolidation. Interestingly, BDNF ASO hindered LTM retention only when given into dorsal CA1 1 h after but not 2 h before training, suggesting that BDNF controls the biphasic requirement of mTOR during LTM consolidation through different mechanisms: an early one involving BDNF already available at the moment of training, and a late one, happening around 3 h post-training that needs de novo synthesis of this neurotrophin. CONCLUSIONS/SIGNIFICANCE: IN CONCLUSION, OUR FINDINGS DEMONSTRATE THAT: 1) mTOR-mediated mRNA translation is required for memory consolidation during at least two restricted time windows; 2) this kinase acts downstream BDNF in the hippocampus and; 3) it controls the increase of synaptic GluR1 necessary for memory consolidation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0006007

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IA Training Is Associated with Two Time Windows of mTOR Activation in the Hippocampus. Bars represent the mean p-mTOR/mTOR ratio of trained (black) or shocked (gray) groups respect to naïve (white) group, sacrificed immediately (A), 15 min (B), 1 h (C), 3 h (D), 9 h (E) or 12 h (F) after IA training. Data are expressed as means±SEM of p-mTOR/mTOR ratio; *p<0.05, **p<0.01. Representative blots of phosphorylated and total protein levels of mTOR are shown in the lower panels. n = 5–6 per group for each experiment.
Figure 1 IA Training Is Associated with Two Time Windows of mTOR Activation in the Hippocampus. Bars represent the mean p-mTOR/mTOR ratio of trained (black) or shocked (gray) groups respect to naïve (white) group, sacrificed immediately (A), 15 min (B), 1 h (C), 3 h (D), 9 h (E) or 12 h (F) after IA training. Data are expressed as means±SEM of p-mTOR/mTOR ratio; *p<0.05, **p<0.01. Representative blots of phosphorylated and total protein levels of mTOR are shown in the lower panels. n = 5–6 per group for each experiment.CC BY · PubMed Central
Figure 2 Cannulae Placements and Drug Infusions. Schematic representations of rat brain sections at three rostrocaudal planes (−3.80, −4.30, and −4.80 from bregma) taken from the atlas of Paxinos and Watson, showing, in stippling, the extension of the area reached by the infusions in the dorsal hippocampus. Reprinted from The Rat Brain in Stereotaxic Coordinates by Paxinos and Watson, pages 33, 35, and 37, Academic Press (1997), with permission from Elsevier.
Figure 2 Cannulae Placements and Drug Infusions. Schematic representations of rat brain sections at three rostrocaudal planes (−3.80, −4.30, and −4.80 from bregma) taken from the atlas of Paxinos and Watson, showing, in stippling, the extension of the area reached by the infusions in the dorsal hippocampus. Reprinted from The Rat Brain in Stereotaxic Coordinates by Paxinos and Watson, pages 33, 35, and 37, Academic Press (1997), with permission from Elsevier.CC BY · PubMed Central
Figure 3 mTOR Signaling Is Required for IA Memory Consolidation During Two Restricted Time Windows After Training. Data are expressed as mean (±SEM) of training (TR, black bars) or test session step-down latency at 24 h (A) or 7 days (B) after IA training. Animals were infused intra-CA1 of the dorsal hippocampus with vehicle (Vh, light grey bars) or rapamycin (4.3 pg/side, dark grey bars), 15 min before or 0, 1, 3, 9, and 12 h after training. Inlet: Rats were infused into the dorsal hippocampus with rapamycin (4.3 pg/side) or vehicle and sacrificed 15 min after drug infusion for analysis of p70S6K activation in the dorsal hippocampus by Western blot. Bars represent the p-p70S6K/p70S6K ratio of rapamycin (white) respect to vehicle (black) treated rats. *p<0.05, **p<0.01, ***p<0.001 vs. Vh for each time point, n = 8–10 per group for each experiment in A and B and n = 5 per group in the inlet.
Figure 3 mTOR Signaling Is Required for IA Memory Consolidation During Two Restricted Time Windows After Training. Data are expressed as mean (±SEM) of training (TR, black bars) or test session step-down latency at 24 h (A) or 7 days (B) after IA training. Animals were infused intra-CA1 of the dorsal hippocampus with vehicle (Vh, light grey bars) or rapamycin (4.3 pg/side, dark grey bars), 15 min before or 0, 1, 3, 9, and 12 h after training. Inlet: Rats were infused into the dorsal hippocampus with rapamycin (4.3 pg/side) or vehicle and sacrificed 15 min after drug infusion for analysis of p70S6K activation in the dorsal hippocampus by Western blot. Bars represent the p-p70S6K/p70S6K ratio of rapamycin (white) respect to vehicle (black) treated rats. *p<0.05, **p<0.01, ***p<0.001 vs. Vh for each time point, n = 8–10 per group for each experiment in A and B and n = 5 per group in the inlet.CC BY · PubMed Central
Figure 4 Different Requirement of BDNF Activity and Synthesis During the Two Time Windows of Memory Consolidation. Data are expressed as mean (±SEM) of training (TR, black bars) or test session step-down latency at 24 h after IA training. Animals were infused intra-CA1 of the dorsal hippocampus with vehicle (Vh, white bars) or function-blocking anti-BDNF antibodies (1 µg/µl, grey bars) 15 min before (A) or 3 h (B) after training. Animals were infused intra-CA1 of the dorsal hippocampus with BDNF MSO (white bar) or BDNF ASO (2 nmol/µl, 1 µg/side, grey bar), 2 h before (C) or 1 h (D) after IA training. *p<0.05, **p<0.01, ***p<0.001 vs Vh (A, B) or MSO (C, D), n = 10 per group for each experiment.
Figure 4 Different Requirement of BDNF Activity and Synthesis During the Two Time Windows of Memory Consolidation. Data are expressed as mean (±SEM) of training (TR, black bars) or test session step-down latency at 24 h after IA training. Animals were infused intra-CA1 of the dorsal hippocampus with vehicle (Vh, white bars) or function-blocking anti-BDNF antibodies (1 µg/µl, grey bars) 15 min before (A) or 3 h (B) after training. Animals were infused intra-CA1 of the dorsal hippocampus with BDNF MSO (white bar) or BDNF ASO (2 nmol/µl, 1 µg/side, grey bar), 2 h before (C) or 1 h (D) after IA training. *p<0.05, **p<0.01, ***p<0.001 vs Vh (A, B) or MSO (C, D), n = 10 per group for each experiment.CC BY · PubMed Central
Figure 5 BDNF Triggers mTOR Activation in the Hippocampus During IA Training and 3 h Thereafter. Bars represent mean p-mTOR/mTOR (A and C) or p-p70S6K/p70S6K ratio (B and D) of rats infused with vehicle (black), function-blocking anti-BDNF antibodies (0.5 µg/side; grey), respect to the naïve group (white). Intra-CA1 infusion of function-blocking anti-BDNF antibodies 15 min before IA training prevents mTOR (A) and p70S6K (B) activation immediately or 15 min after training respectively and infusion 2∶45 h after training prevents mTOR (C) and p70S6K (D) activation 3 h after training. Representative blots of phosphorylated and total protein levels of mTOR and p70S6K are shown in the lower panels. *p<0.05, **p<0.01, n = 5–6 per group for each experiment.
Figure 5 BDNF Triggers mTOR Activation in the Hippocampus During IA Training and 3 h Thereafter. Bars represent mean p-mTOR/mTOR (A and C) or p-p70S6K/p70S6K ratio (B and D) of rats infused with vehicle (black), function-blocking anti-BDNF antibodies (0.5 µg/side; grey), respect to the naïve group (white). Intra-CA1 infusion of function-blocking anti-BDNF antibodies 15 min before IA training prevents mTOR (A) and p70S6K (B) activation immediately or 15 min after training respectively and infusion 2∶45 h after training prevents mTOR (C) and p70S6K (D) activation 3 h after training. Representative blots of phosphorylated and total protein levels of mTOR and p70S6K are shown in the lower panels. *p<0.05, **p<0.01, n = 5–6 per group for each experiment.CC BY · PubMed Central
Figure 6 IA Training Induces GluR1 Expression in Hippocampal Synaptic Plasma Membranes-Enriched Fractions Through BDNF/mTOR Pathway. Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of trained (black) respect to naïve (white) rats 15 min (A) or 3 h after IA training (B). Rats infused intra-CA1 of the dorsal hippocampus 15 min before and sacrificed 15 min after training (B and C) or 2∶45 h and sacrificed 3 h both after training (E and F) with vehicle (black) or function-blocking anti-BDNF antibodies (0.5 µg/side; dark grey) (C and E) or rapamycin (4.3 pg/side; light grey) (D and F). Representative blots of total GluR1 protein levels and actin are shown in the lower panels *p<0.05, **p<0.01, ***p<0.001, n = 5–7 per group.
Figure 6 IA Training Induces GluR1 Expression in Hippocampal Synaptic Plasma Membranes-Enriched Fractions Through BDNF/mTOR Pathway. Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of trained (black) respect to naïve (white) rats 15 min (A) or 3 h after IA training (B). Rats infused intra-CA1 of the dorsal hippocampus 15 min before and sacrificed 15 min after training (B and C) or 2∶45 h and sacrificed 3 h both after training (E and F) with vehicle (black) or function-blocking anti-BDNF antibodies (0.5 µg/side; dark grey) (C and E) or rapamycin (4.3 pg/side; light grey) (D and F). Representative blots of total GluR1 protein levels and actin are shown in the lower panels *p<0.05, **p<0.01, ***p<0.001, n = 5–7 per group.CC BY · PubMed Central
Figure 7 GluR1 Translation Is Required for IA Memory Consolidation During Training and 3 h Thereafter. (A) Animals were injected with Vehicle (black bar) or CNQX immediately, 1 h or 3 h after IA training (grey bars). Data are expressed as mean (±SEM) of training (TR, white bars) or test session step-down latency at 24 h after IA training. (B and C) Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR (grey bar) or MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C). (D and E) Animals were injected with MSO (black bar) or GluR1 ASO (grey bar) 2 h pre-TR (D) or 1 h after TR (E). Data are expressed as mean (±SEM) of training (TR, white bars) or test session step-down latency at 24 h after IA training. (F and G) Bars represent the mean GluR2/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR (grey bar) or MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C). *p<0.05, **p<0.01, ***p<0.001, n = 10–14 per group for each experiment in figures A, D and E; n = 5 per group for each experiment in figures B, C, F and G.
Figure 7 GluR1 Translation Is Required for IA Memory Consolidation During Training and 3 h Thereafter. (A) Animals were injected with Vehicle (black bar) or CNQX immediately, 1 h or 3 h after IA training (grey bars). Data are expressed as mean (±SEM) of training (TR, white bars) or test session step-down latency at 24 h after IA training. (B and C) Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR (grey bar) or MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C). (D and E) Animals were injected with MSO (black bar) or GluR1 ASO (grey bar) 2 h pre-TR (D) or 1 h after TR (E). Data are expressed as mean (±SEM) of training (TR, white bars) or test session step-down latency at 24 h after IA training. (F and G) Bars represent the mean GluR2/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR (grey bar) or MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C). *p<0.05, **p<0.01, ***p<0.001, n = 10–14 per group for each experiment in figures A, D and E; n = 5 per group for each experiment in figures B, C, F and G.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 246

Related

See all

Metadata

Authors
Slipczuk, L., Bekinschtein, P., Katche, C., Cammarota, M., Izquierdo, I., & Medina, J. H.
Affiliations
  • Universidad de Buenos Aires (AR)
  • Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Corresponding author
Medina, Jorge H.
ORCID
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2009-06-23
Volume
4
Issue
6
Pages
e6007
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0006007
PMC
PMC2695538
OpenAlex
W2035139662
Cited by
246
References
90
Citations by year
2026: 3 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 13 · 2021: 10 · 2020: 19 · 2019: 1 · 2018: 14 · 2017: 21 · 2016: 19 · 2015: 20 · 2014: 23 · 2013: 19 · 2012: 29
FWCI
10.85
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
brain-derived neurotrophic factor, mTOR signaling, GluR1, AMPA receptors, long-term memory consolidation, passive avoidance, fear memory, hippocampus, CA1, p70S6K, antisense oligonucleotides
MeSH terms
Animals, Hippocampus, Male, Memory, Models, Biological, Neuronal Plasticity, Protein Kinases, RNA, Messenger, Synapses, Time Factors, Rats, Wistar, Receptors, AMPA, Brain-Derived Neurotrophic Factor, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review